Gynecologic Oncology Group 86th Semi-Annual Meeting

Semi‐Annual Meeting: January 24‐27, 2013 

Exhibit Hall: January 25‐26, 2013 

Manchester Grand Hyatt 

San Diego, CA 

The GOG welcomes you to Exhibit at the

upcoming GOG Semi-Annual Meeting!

The Gynecologic Oncology Group invites you to participate as an exhibitor at the upcoming GOG Semi‐Annual Meeting 

held at the Manchester Grand Hyatt in San Diego, CA from January 24 ‐ 27, 2013. 

The Gynecologic Oncology Group hosts two Semi Annual Meetings each year.  The meeting consists of several meetings 

and workshops (ovarian, cervix, corpus, pathology, medical informatics, radiation, cancer prevention, etc.) to provide an 

exchange of information, establish criteria for evaluation of protocol compliance and review.   

The purpose of the exhibits is to allow companies an opportunity to inform the membership about drugs, supplies and   services that are available in the field of gynecologic oncology.     Each  Exhibiting  Company will  receive  a  complimentary  listing  in  the  Final  Agenda  Program.    This  program will  be  distributed to over 900 meeting attendees.   

Hotel Reservations  (available October 2012) 

Exhibitors are responsible for making their own reservations.  Reservations must be made via PassKey website for the Manchester  Grand  Hyatt  In  San  Diego.  Reservations  can  be  made  online  through  the  GOG  website  at  http://www.gog.org/meetinginformation.html.  Click the tab for Hotel. 

Registration   (available October 2012) 

All onsite representatives must register to receive an Exhibitor Name Badge.  To register please complete the attached Exhibit Space Application.  Exhibitors are entitled to 3 complimentary name badges per exhibit table.  Additional onsite representatives must pay a fee of $100.00. 

For more information please contact the Director of Exhibits, at 215‐854‐0770 or dmackey@gog.org. 

Exhibitors  make a significant contribution to the  GOG Meetings.  Thank you for your consideration.   

We hope you will be joining us in San Diego! 

 

 

GOG Exhibit Hours 

Friday, January 25, 2013‐ 7:00 am ‐ 5:00 pm 

Saturday, January 26, 2013‐ 7:00 am ‐ 5:00 pm 

 

Exhibit Installation Hours  

Exhibit Set‐up begins:  3:00 pm, Thursday, January 24, 2013 

Exhibits must be dismantled by:  6:00 pm, Saturday, January 26, 2013 

2

G O G  M i s s i o n   S t a t e m e n t    

The Gynecologic Oncology Group is a non‐profit organization with the purpose of promoting excellence in the quality and integ‐rity of clinical and basic scientific research in the field of gynecologic malignancies.  The Group is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results.  Continuous evaluation of our 

processes is utilized in order to constantly improve the quality of patient care. 

 

2….…..Welcome/General Information 

 

4.……..About the GOG and the Group Meetings 

 

5………GOG Exhibitor Rules & Regulations 

 

7……….Phantom Booth Option 

 

8……..Preliminary Agenda 

 

9………Exhibit Space Application 

 

11………Your Company’s Objective 

 

12……...Previous Exhibitors

3

Radiation Oncologists Pathologists Basic Scientists Nurse Oncologists Statisticians Data Managers Administrative Personnel E d u c a t i o n a l O b j e c t i v e s o f t h i s M e e t i n g

1. To inform the participants at the semi-annual meetings as to the most current state of clinical and basic research in gynecologic oncology, particularly, but not exclusively as it relates to clinical field trials by:

Progress reports of recent completed GOG studies, cancer center activities, and work of other groups and efforts of individual investigators.

Status update of current trials, whether a group or non-group in origin.

Projections of future clinical programs to diagnose treat and/or prevent cancer.

2. To provide participants with peer review critique of pro-gress (or lack of it) with the objective of self-improvement:

Identify strengths and weakness of individual investi-gators and their institutions.

Counsel investigators in corrective procedures to obtain better research and better-reported data.

Set up detailed programs for quality and productivity from a basic foundation of education of the investiga-tor in research objectives and procedures.

3. To provide an opportunity to learn research administration and financial management in a cooperative group setting.

4. To provide a lecture type forum of reports from experts from many fields that may relate to better research of patient man-agement.

The GOG has as its main objective to provide an appropriate instrument to test new ideas for prevention of female pelvic ma-lignancies and management of patients with such malignancies. Currently over 3,300 patients are registered each year to GOG research trials.

A b o u t t h e G r o u p The Gynecologic Oncology Group “GOG” is one of the National Cancer Institute’s (NCI) funded cooperative cancer research groups. GOG is the only group, which focuses its research on women with pelvic malignancies, such as cancer of the ovary, uterus and cervix.

The GOG was organized in 1970 by a group of gynecologic surgeons with a special interest in quality clinical research. They recognized the need for a collaborative research effort, not only among institutions, but also among the various disciplines involved in the treatment of women with gynecologic cancers. The GOG was among the first organizations to adopt a multidis-ciplinary, multi-institutional, prospective approach to the man-agement of pelvic malignancies in women.

Since 1970, the GOG has grown from 11 original member insti-tutions to over 60 principal centers, most of which are academic centers and over 160 affiliate institutions. The GOG is a multi-modality group with over twenty-one hundred participants. The GOG is the foremost multidisciplinary cooperative clinical trials research group devoted to the study of gynecologic malignan-cies in the world. The GOG is recognized as the leader in the development of new procedures in each of the relevant diagnos-tic and therapeutic disciplines.

P u r p o s e o f E x h i b i t The purpose of the exhibits is to allow companies an opportunity to inform the membership about drugs, supplies and services that are available in the field of gynecologic oncology.

A t t e n d e e s a t o u r M e e t i n g s The GOG Semi-Annual Meeting attendance totals over 900 attendees. The attendance is made up of: Gynecologic Oncologists Medical Oncologists

About the Gynecologic Oncology Group

and the Group Meetings

4

Applications for space for an Exhibit at the Semi Annual Meeting should be submitted before December 7, 2012. The Director of Exhibits, will act on applications as soon after that date as possible, and GOG will notify exhibitors of booth assignments. Please note that exhibit space is limited, therefore any applications received after December 7, 2012 may not be accommodated. Every effort will be made to assign adequate space to exhibitors according to their re-quirements.

SPACE

Rental of the space includes draped (1) 6’ x 30’’ table and (2)chairs. The exhibitor is responsible for sign. Any data or electrical needs are the responsibility of the Exhibitor. Information regarding these services will be provided after we have received your appli-cation.

USE OF SPACE

No exhibit shall interfere with another exhibit. Signs, motion pic-tures, public address apparatus, loud speaking records and tapes are not permitted without special permission.

SUBLETTING OF SPACE

Subletting of space will not be permitted. The principal exhibitor must sign the application for space. The principal exhibitor may not have materials, representatives or equipment from any organi-zation other than his or her own.

ELIGIBILITY

An organization that has a product or service that is related to the field of gynecology is eligible to exhibit at the Gynecologic Oncology Group (GOG) Semi Annual Meeting. All exhibitor appli-cations must be approved by the GOG in advance of the meeting.

EXHIBIT HOURS

For your convenience, all Continental Breakfast and Beverage Breaks will be held in the Exhibitor Display Area.

GOG Exhibit Hours Friday, January 25, 2013 - 7:00 a.m. – 5:00 p.m. Saturday, January 26, 2013 - 7:00 a.m. – 5:00 p.m. INSTALLATIONS AND DISMANTLING Installation of exhibits may begin after 3:00 pm on Thursday, Janu-ary 24, 2013. Exhibits must be removed by 6:00 pm Saturday, January 26, 2013. Any charges for Shipping, Installation and Dis-mantling is the responsibility of the Exhibitor.

INSURANCE

It is the responsibility of each exhibitor to maintain insurance against injury, property damage, theft, fire, and any other forms of property loss or injury. GOG requires that all exhibitors maintain general liability insurance in the amount of $1,000,000 and must name the Gynecologic Oncology Group as an additional insured for the period January 24, 2013 through January 27, 2013.

Please mail to:

Director of Exhibits Gynecologic Oncology Group Administrative Office Suite 1020 Four Penn Center 1600 JFK Blvd., Suite 1020 Philadelphia, PA 19103 COST

The cost of one (1) tabletop exhibit: Early Bird Sept. 11 - Oct. 17: $2,000.00

(Early Bird Payment must be received in our office by Oct. 17) Prior to December 7, 2012: $2,500.00 After December 7, 2012: $3,000.00 An additional table cost: $1,000.00 This fee is for the draped table and chairs only. Exhibitors must pay the costs of any electrical or other special requirements directly to hotel. Space will be assigned on a first-come first-serve basis. Once an application with full payment is received, you will be sent a confirmation letter that will include your table number. All checks should be made payable to the Gynecologic Oncology Group. REGISTRATION

All exhibitors must register as an exhibitor to receive name badges. Exhibitors are entitled to 3 complimentary badges per Exhibit Table. Exhibitors can pick up their badges at the meeting registration desk. LITERATURE FOR DISTRIBUTION

All new exhibitors must submit sample copies of all literature to be distributed, and must accompany the Application for Space, or be forwarded as soon as available to the Director of Exhibitors. GOG has the right to forbid distribution of any material. DEMONSTRATIONS

Competent, well-informed demonstrators must be in charge of all

GOG Exhibitor Rules and Regulations

5

exhibits and must be present during all intermissions.

LIABILITY, HOLD HARMLESS:

Exhibitor hereby agrees to and does indemnify, hold harmless and defend GOG from and against any and all liability, responsibility, loss, damage, cost, or expense of any kind whatsoever (including attorney’s fees) which GOG may incur, pay or be required to pay, incident to or arising directly or indirectly from any intentional or negligent act or omission by Exhibitor or any of its employees, or agents. GOG, and its respective agents and employees shall not be responsible in any way for 1) damage, loss or destruction of any property of Exhibitor or 2) injury to exhibitor or its representa-tive, agents, employees, licensees, or invitees.

PENALTIES

Failure to have an exhibit installed on time, to keep exhibit intact until closing time or other infractions of the rules set forth in this Prospectus or established by the Hotel may result in penalties pre-scribed by the Director of Exhibits.

SHIPPING INSTRUCTIONS (Information to follow after we receive your registration form and payment)

CANCELLATION

In the event that the Semi Annual Meeting is postponed due to any occurrence not occasioned by the conduct of GOG or Exhibitor, whether such occurrence be an Act of God or the common enemy or the result of war, riot, civil commotion, sovereign conduct, or the act or conduct of any third party, then the performance of the parties of their respective meeting obligations shall be excused for such period of time as is reasonably necessary after such occurrence to remedy the effects thereof. If the occurrence results in cancellation of the meeting, the obligations of the parties under applicable agree-ments shall automatically be terminated and all exhibit payments shall be refunded to Exhibitor, less a pro rate shall of expenses actually incurred by GOG in connection with the meeting.

F O R F U R T H E R I N F O R M A T I O N C O N T A C T

Director of Exhibits Gynecologic Oncology Group (GOG)

Administrative Office Four Penn Center

1600 John F. Kennedy Blvd. – Suite 1020 Philadelphia, PA 19103

215-854-0770 Phone 215-854-0716 Fax Email - dmackey@gog.org

GOG Exhibitor Rules and Regulations continued

6

Please note: Your company is responsible for all shipping costs. 

All submitted materials are subject to approval by GOG. 

Phantom Booth Option 

Are you unable to attend the GOG 86th Semi ‐ Annual  Meeting?  

No Problem! 

Your company can still exhibit without actually being present! 

Take advantage of our: 

Your company flyers, brochures, promotional items, and other information can be on display 

at an unattended booth.  

Registration and Payment must be in our office no later than December 7, 2012. 

You will be contacted with details about where to ship your materials after your registration 

and payment have been received.  

For more information, please contact the GOG Administrative Office at 215 ‐ 854 ‐ 0770 or 

email dmackey@gog.org 

Registration form and payment may be sent to the following address: 

Gynecologic Oncology Group 

Administrative Office 

Four Penn Center 

1600 John F. Kennedy Blvd., Suite 1020 

Philadelphia, PA 19103 

Attn: Exhibits Manager 

Please make checks out to : Gynecologic Oncology Group 

Company Name___________________________________________________________

Contact Name_____________________________________________________________

Telephone_________________________________ Email__________________________

Phantom Booth Fee………………………………………………………………$1500.00

Please provide a brief description of items you intend to be displayed: 

7

Thursday, January 24, 2013

3 pm - 6 pm Installation of Exhibits

6:30 pm - 8:30 pm GOG Reception

Friday, January 25, 2013

7 am Meeting Registration Open

7am – 8 am Protocol Committee Executive Session - Closed

7 am - 9 am Continental Breakfast

7 am – 9 am Nursing Workshop

7 am – 6 pm Information Technology Resource Center

8 am – 10 am Ovarian Workshop

8 am – 10 am Cervix Workshop

8 am – 10 am Corpus Workshop

8 am – 5 pm GYN Review – Closed

8 am – 5 pm Pathology Workshop & Review

7 am – 5 pm Exhibits

9 am – 10 am Welcome To New Data Managers

10:30 am – 12 pm Opening General Session

12:30 pm – 3 pm Cancer Prevention & Control Workshop

1 pm – 5 pm Radiation Oncology Workshop

1 pm – 2:30 pm Phase I Subcommittee

1 pm – 2:30 pm Tissue Utilization Subcommittee

1:30 pm – 3:30 pm GYN Oncology Workshop

1:30 pm – 3:30 pm Data Management Workshop

2:30 pm – 4:30 pm Developmental Therapeutics Workshop

2:30 pm – 4:30 pm Health Outcomes Research Workshop

3 pm – 5 pm DMC - Closed

3:30 pm – 4:30 pm Workshop on Experimental Medicine &

Cancer Prevention & Control -

Combined Meeting 4 pm - 7 pm Workshop on Information Technology

4:30 pm - 5:30 pm Workshop on Experimental Medicine

5:30 pm - 6:00 pm PI’s Meeting (Closed)

4:30 pm – 5:30 pm CCOP Meeting

4:30 pm – 6 pm Workshop on Experimental Medicine

4:30 pm – 6:30 pm Medical Oncology Workshop

Saturday, January 27, 2013

7 am Meeting Registration Open

7am – 8 am Nursing Workshop

7 am - 8 am Trophoblastic Subcommittee

7 am - 9 am Continental Breakfast

7 am – 6 pm Information Technology Resource Center

7:30 am – 9:30am Workshop on Experimental Medicine (9-9:30

Combined with Dev. Therapeutics)

8 am – 9 am DSMB - Closed

8 am – 9 am Nursing & Data Management Workshops Combined Meeting

8 am – 10 am Cancer Prevention & Control Workshop

8 am—10 am Developmental Therapeutics & Phase I 7 am – 5 pm Exhibits 8 am – 5 pm Pathology Workshop & Review

8 am – 5 pm GYN Review – Closed

9 am – 10 am Data Management Workshop

9 am - 10 am Publications Subcommittee

9 am – 10 am DMC - Closed

10 am – 11 am Membership Committee – Closed

10 am – 12 pm Cervix Workshop

10 am – 12 pm Ovarian Workshop

10 am – 12 pm Corpus Workshop

10 am – 12 pm GOG HRC - Closed

12 pm – 1 pm DMC/DSMB/HRC/Pat adv - Lunch

(Committees only)

12 pm – 1 pm Health Outcomes Research Workshop

1 pm – 1:15 pm Board of Directors – Closed

2 pm - 7 pm Protocol Development Workshop

5 pm - 6 pm Dismantling of Exhibits

The Gynecologic Oncology Group 86th Semi-Annual Meeting

January 24 - 27, 2013 - San Diego, CA

*Agenda is subject to change

Preliminary Agenda*

8

Please list Principal Exhibitor Contact:

Contact Name Title

Contact Mailing Address

City State Zip

Contact Phone Contact Fax Contact Email

Registration: Please List On-Site Representative Names (Three Complimentary Badges per Table):

(1) On-site Representative (2) On-site Representative

(3) On-Site Representative

Additional On-Site Representatives must pay the GOG Registration Fee of $100:

(1) Additional On-site Representative ($100) (2) Additional On-site Representative ($100)

The Gynecologic Oncology Group 86th Semi-Annual Meeting

January 24 - 27, 2013 - San Diego ,CA

Please list Company Name exactly as it should appear in Final Agenda Program and Exhibit Sign:

Company Name

Mailing Address

City State Zip

Company Phone Company Fax Company Email

Company Website Address Please indicate any special Requests regarding Exhibit Space

Exhibit space will be located in close proximity to the GOG meeting registration area. Exhibit dates are Friday, January 25, 2013, 7:00 am to 5:00 pm and Saturday, January 26, 2013, 7:00 am to 5:00 pm.

Exhibitor agrees to and does indemnify, hold harmless and defend GOG from and against any and all liability, responsibility, loss, damage, cost, or expense of any kind whatsoever (including attorney’s fees) which GOG may incur, pay or be required to pay, incident to or arising directly or indirectly from any intentional or negligent act or omission by Exhibitor or any of its employees, or agents. GOG, and its respective agents and employees shall not be responsible in any way for 1) damage, loss or destruction of any property of Exhibitor or 2) injury to exhibitor or its repre-sentative, agents, employees, licensees, or invitees.

9

Payment - Cost of Exhibit Space:

$ 2,000 Early Bird - September 11th — October 17th

$ 2,500 prior to December 7, 2012

$ 3,000 After December 7, 2012

$__________ Additional On-Site Representatives ($100 each)

ICT Member (Fee Included in Membership) For more information regarding ICT Membership please contact Kathy Shumaker at 410-721-7126 or kshumaker@gog.org Please Contact the GOG Administrative Office for Publisher’s Exhibit Rates.

Total $____________________

METHOD OF PAYMENT - GOG Accepts Checks, MasterCard and VISA ONLY

Account #_____________________________________________________________ Exp. Date________________

Check (Make Payable to Gynecologic Oncology Group) e

e

Amount Enclosed $____________________________

For GOG use Only

Table Assigned: _______________ Total Paid: ___________________ Check # ____________________ Date Received ____________________

Send payment with application form to :

Director of Exhibits Gynecologic Oncology Group (GOG)

Administrative Office Four Penn Center

1600 John F. Kennedy Blvd., Suite 1020 Philadelphia, PA 19103

Fax to : 215-854-0716 or Email to: dmackey@gog.org

The Gynecologic Oncology Group 86th Semi-Annual Meeting

January 24 - 27, 2013 - San Diego, CA

I understand that this covers the following: (1) 6ft x 30 in table with draping. I further understand that all display material must be fire proof and subject to inspection by the local Fire Marshall. No flammable fluids or substances may be used.

Written requests for cancellation must be received by December 7, 2012 to receive a full refund, less a $100.00 administrative fee. Any Cancella-tions after December 7th will receive a 50% refund, less $100.00 administrative fee. There will be no refunds for any cancellations after January 7, 2013.

THE UNDERSIGNED AGREES TO BE BOUND BY THE TERMS AND CONDITIONS CONTAINED IN THE PROSPECTUS ACCOMPANYING THIS APPLICATION.

Signature of Principle Exhibitor Contact __________________________________________ Date _________________

Page 2 of Application 

10

 

 YOUR COMPANY’S OBJECTIVE   

The GOG looks forward to your participation as an exhibitor in this years January 2013 Semi‐Annual meeting in San Diego, CA.  We are requesting a brief 4‐5 line synopsis of your company’s objective.  This information is mandatory for our Final Agenda Program which will be distributed at the meeting.  Your company’s objective is due in our office by December 7, 2012. Please forward all responses via email to the Exhibits Coordinator  at agibson@gog.org or fax to (267) 295‐9485. 

 

Please Print Clearly 

Company Name _________________________________________________________ 

(Please list company name exactly as it should appear in Final Agenda Program) 

 

Company Objective 

________________________________________________________________________

________________________________________________________________________

________________________________________________________________________

________________________________________________________________________

________________________________________________________________________ 

   

The Gynecologic Oncology Group 86th Semi-Annual Meeting

January 24 - 27, 2013 - San Diego, CA

Page 3 of Application 

11

Previous GOG Semi-Annual Meeting Exhibitors

Abraxis Bioscience, LLC. 

Advaxis, Inc. 

AcerMed, Inc. 

Advocate Christ Medical Center 

American Cancer Society 

Amgen, Inc. 

Althea Technologies, Inc. 

Aventis Pharmaceuticals 

Banner Health 

Baxter 

Belmont Instrument Corporation  

Boehringer Ingelheim Pharmaceuticals, Inc. 

Biogen Idec 

Bristol Myers Squibb 

Cancer Trials Support Unit (CTSU) 

Caris Life Sciences 

Champions Oncology 

Celgene Corporation 

Cell Therapeutics Inc. 

Centocor Othoro Biotech Products, L.P. 

Coalition of National Cancer Cooperative Groups 

Cytyc Corporation 

DDOTS 

Digene Corporation 

The Doctor Shop 

Egen, Inc. 

Eli Lilly and Company  

Elsevier (Saunders & Mosby) 

Endocyte 

Exiqon Diagnostics, Inc. 

Foundation for Women’s Cancer 

Fujirebio Diagnostics, Inc. 

Genzyme Biosurgery 

GlaxoSmithKline 

Gynecologic Cancer Foundation 

Gyrus ACMI 

HCA Physician Recruitment 

Hospital Corporation of America (HCA) 

I‐FLOW Corporation 

Impath, Inc. 

Impedi Med, Inc. 

International Gynecologic Cancer Society 

Janssen Products, LP 

Joey Med, LLC 

Laclede, Inc. 

Lippincott, Williams & Wilkins 

Marina Medical Instruments, Inc.   

MAST Biosurgery 

MedImmune Oncology, Inc. 

Medison America, Inc. 

Merck Oncology 

Meridian Health 

MGI Pharma. Inc. 

Monogen, Inc. 

Morphotek, Inc 

Myriad Genetic Laboratories 

National Cervical Cancer Coalition (NCCC) National Ovarian Cancer Coalition 

Olympus‐Gyrus ACMI 

Onco, Inc. 

ONCOTECH 

Ortho Biotech Products, L.P. 

Owen Mumford, Inc. 

Ovagene 

Oxigene, Inc 

Pathwork Diagnostics PharmaNet Development Group 

Plasma Surgical, Inc. 

Prime Clinical Systems 

Precision Therapeutics 

Smiths Medical MD 

Society of Gynecologic Oncologists 

Tactile Systems Technology 

Tibotec Therapeutics 

TriPath Imaging Inc. 

W.B. Saunders/Mosby 

Westat/CTSU 

Vermillion, Inc 

12

Save The Date! Gynecologic Oncology Group 87th Semi - Annual Meeting

July|18-21, 2013

Marriott River Center San Antonio, TX

13

 

 

Gynecologic Oncology Group 

Administrative Office 

Four Penn  Center 

1600 John F. Kennedy Blvd., Suite 1020 

Philadelphia, PA 19103 

Phone ‐ 215‐854‐0770 

Fax ‐ 215‐854‐0716 

Website ‐ www.gog.org 

July 18‐21, 2013 

Marriott River Center 

San Antonio, TX 

 

January 23‐26, 2014 

Manchester Grand Hyatt 

San Diego, CA 

 

July 17 ‐ 20, 2014 

Hyatt Regency Chicago 

Chicago, IL 

 

January 22‐25, 2015 

Manchester Grand Hyatt 

San Diego, CA 

 

July 16‐19, 2015 

Sheraton Hotel 

Denver, CO 

Save the Date for these upcoming 

GOG Semi‐Annual Meetings:      

8 6 t h   S em i ‐ A n n u a l  Me e t i n g  

J a n u a r y   2 4 ‐ 2 7 ,   2 0 1 3  

GOG Gynecologic Oncology Group 

14